首页> 美国卫生研究院文献>Molecular and Cellular Biology >The CRY1 gene in Chlamydomonas reinhardtii: structure and use as a dominant selectable marker for nuclear transformation.
【2h】

The CRY1 gene in Chlamydomonas reinhardtii: structure and use as a dominant selectable marker for nuclear transformation.

机译:Reinhardtii衣藻中的CRY1基因:结构和用作核转化的主要选择标记。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We have cloned and sequenced the CRY1 gene, encoding ribosomal protein S14 in Chlamydomonas reinhardtii, and found that it is highly similar to S14/rp59 proteins from other organisms, including mammals, Drosophila melanogaster, and Saccharomyces cerevisiae. We isolated a mutant strain resistant to the eukaryotic translational inhibitors cryptopleurine and emetine in which the resistance was due to a missense mutation (CRY1-1) in the CRY1 gene; resistance was dominant in heterozygous stable diploids. Cotransformation experiments using the CRY1-1 gene and the gene for nitrate reductase (NIT1) produced a low level of resistance to cryptopleurine and emetine. Resistance levels were increased when the CRY1-1 gene was placed under the control of a constitutive promoter from the ribulose bisphosphate carboxylase/oxygenase small subunit 2 (RBCS2) gene. We also found that the 5' untranslated region of the CRY1 gene was required for expression of the CRY1-1 transgene. Direct selection of emetine-resistant transformants was possible when transformed cells were first induced to differentiate into gametes by nitrogen starvation and then allowed to dedifferentiate back to vegetative cells before emetine selection was applied. With this transformation protocol, the RBCS2/CRY1-1 dominant selectable marker gene is a powerful tool for many molecular genetic applications in C. reinhardtii.
机译:我们已经克隆和测序了编码莱茵衣藻中核糖体蛋白S14的CRY1基因,并发现它与其他生物(包括哺乳动物,果蝇和啤酒酵母)的S14 / rp59蛋白高度相似。我们分离了一个对真核翻译抑制剂隐性小ine碱和美金汀具有抗性的突变株,其中的抗性是由于CRY1基因的错义突变(CRY1-1)引起的。抗性在杂合稳定的二倍体中占主导地位。使用CRY1-1基因和硝酸还原酶基因(NIT1)进行的共转化实验产生了对隐性小ine碱和依替丁的低水平耐药性。当将CRY1-1基因置于来自核糖双磷酸羧化酶/加氧酶小亚基2(RBCS2)基因的组成型启动子的控制下时,抗性水平增加。我们还发现,CRY1-1转基因的表达需要CRY1基因的5'非翻译区。当首先通过氮饥饿诱导转化细胞分化为配子,然后在应用依替丁选择之前,使其先分化为营养细胞,就可以直接选择依替丁抗性转化子。通过这种转化方案,RBCS2 / CRY1-1显性选择标记基因是在莱茵衣藻中许多分子遗传学应用的强大工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号